Business expansion: Abbott plans to focus on cardiovascular devices and diagnostics. – AP
BENGALURU: Abbott Laboratories said it would sell its eye care business to Johnson & Johnson (J&J) for about US$4.33bil in cash to focus on cardiovascular devices and diagnostics business.
The company expanded its medical device and diagnostics businesses this year with a US$25bil deal for St Jude Medical Inc and a US$5.8bil deal for Alere Inc.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
